EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.569
https://www.valueinhealthjournal.com/article/S1098-3015(24)00684-3/fulltext
Title :
EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00684-3&doi=10.1016/j.jval.2024.03.569
First page :
Section Title :
Open access? :
No
Section Order :
10050